Home > Income Statement > GLAND PHARMA

GLAND PHARMA
Revenue

    Back to Income Statement
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹5,665 Cr₹3,625 Cr₹4,401 Cr₹3,463 Cr₹2,633 Cr

What is the latest Revenue of GLAND PHARMA ?

The latest Revenue ratio of GLAND PHARMA is ₹5,665 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹5,665 Cr
Mar2024₹3,625 Cr
Mar2023₹4,401 Cr
Mar2022₹3,463 Cr
Mar2021₹2,633 Cr

How is Revenue of GLAND PHARMA Trending?

Years Revenue % Change
Mar2025 ₹5,665 Cr
56.29
Mar2024 ₹3,625 Cr
-17.64
Mar2023 ₹4,401 Cr
27.08
Mar2022 ₹3,463 Cr
31.51
Mar2021 ₹2,633 Cr -

Compare Revenue of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,086.0 Cr 1.4% 2.4% 3.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,497.0 Cr -3.5% -6.4% -2.6% Stock Analytics
DIVIS LABORATORIES ₹165,492.0 Cr -5.8% -1.6% 10.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,013.0 Cr 1.4% 7% 23.7% Stock Analytics
CIPLA ₹112,922.0 Cr -4.7% -6.8% -0.3% Stock Analytics
DR REDDYS LABORATORIES ₹98,115.0 Cr -2.8% -8.1% -11.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

1.4%

2.4%

3.7%

SENSEX

-0.7%

-1.9%

8%


You may also like the below Video Courses